Contents
Download PDF
pdf Download XML
425 Views
121 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 254 - 257
Mycobacterium w, New Hope to Sepsis Patients: Initial Experience from Single center
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
April 20, 2023
Abstract

Background: Mycobacterium wis an immunomodulatorthat evokes antigen-specific cell-mediated immunity and its use has been evaluated in patients with sepsis, where it resulted in improved outcome.  Methods: We collected data in ten adult patientswith suspected gram-negative sepsis admitted inthe intensive care unit. Injection Mw 0.3 ml was administered intradermal per day for three consecutive days alongwith continuation of standard care. Results: We observed clinical improvement and a significant decrease in TLC and SOFA Score on day 7 after Mw administration. Also, Mw was not associated with any local or systemic adverse effects. Conclusion: The use of Mw was safe and effective in patients with sepsis, though larger randomized trials are required to establish its role.

Keywords
Recommended Articles
Research Article
A Study on Cardiovascular Dysfunction in End Stage Renal Disease Patients on Haemodialysis using Echocardiography
...
Published: 29/10/2025
Download PDF
Research Article
Rotational Atherectomy versus Cutting Balloon Angioplasty in Severely Calcified Coronary Lesions: A Prospec-tive Single-Center Comparative Study
...
Published: 29/10/2025
Download PDF
Research Article
Clinical Epidemiology of Carcinoma of Prostate: An Eastern India scenario
Published: 28/10/2025
Download PDF
Research Article
I-gel versus Endotracheal Tube for Airway Management in Elective Laparoscopic Cholecystectomy: A Prospective Randomized Study
...
Published: 29/10/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.